Literature DB >> 3474144

Prostaglandin production by calvariae from sham operated and oophorectomized rats: effect of 17 beta-estradiol in vivo.

J H Feyen, L G Raisz.   

Abstract

The mechanism by which estrogen inhibits bone resorption in vivo is not known. Since prostaglandin E2 (PGE2) is a potent stimulator of bone resorption in vitro, we tested the hypothesis that estrogens might affect bone indirectly by inhibiting endogenous PGE2 synthesis. Cultured parietal bones from 7- to 9-week-old rats showed a gradual release of immunoreactive PGE2 in vitro. Oophorectomy resulted in a two-fold increase in PGE2 release. Treatment in vivo with low doses of 17 beta-estradiol or high doses of 17 alpha-estradiol 26 h and 2 h prior to sacrifice inhibited bone PGE2 release in vitro. Addition of 17 beta-estradiol to calvariae in vitro did not affect PGE2 release, whereas cortisol inhibited PGE2 release.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3474144     DOI: 10.1210/endo-121-2-819

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

Review 1.  A risk-benefit assessment of estrogen therapy in postmenopausal women.

Authors:  M P Cust; K F Gangar; T C Hillard; M I Whitehead
Journal:  Drug Saf       Date:  1990 Sep-Oct       Impact factor: 5.606

Review 2.  Role of oestrogen in the development of osteoporosis.

Authors:  T C Hillard; J C Stevenson
Journal:  Calcif Tissue Int       Date:  1991       Impact factor: 4.333

3.  Enhanced osteoblast proliferation and collagen gene expression by estradiol.

Authors:  M Ernst; C Schmid; E R Froesch
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

4.  Direct effects of 17 beta-estradiol on trabecular bone in ovariectomized rats.

Authors:  T Takano-Yamamoto; G A Rodan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

Review 5.  That oestrogen replacement for osteoporosis prevention should no longer be a bone of contention.

Authors:  T G Palferman
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

6.  Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae.

Authors:  H Kawaguchi; C C Pilbeam; S J Vargas; E E Morse; J A Lorenzo; L G Raisz
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 7.  Prostaglandins: mechanisms of action and regulation of production in bone.

Authors:  L G Raisz; C C Pilbeam; P M Fall
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

Review 8.  Prevention of osteoporosis. Current recommendations.

Authors:  M C Ellerington; J C Stevenson
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923

9.  Estrogen potentiates the combined effects of transforming growth factor-beta and tumor necrosis factor-alpha on adult human osteoblast-like cell prostaglandin E2 biosynthesis.

Authors:  F J Secreto; A Grover; M Pacurari; M B Rice; M Kantorow; A P Bidwai; J D Blaha; P E Keeting
Journal:  Calcif Tissue Int       Date:  2003-09-10       Impact factor: 4.333

10.  The Anti-Inflammatory, Phytoestrogenic, and Antioxidative Role of Labisia pumila in Prevention of Postmenopausal Osteoporosis.

Authors:  M E Nadia; A S Nazrun; M Norazlina; N M Isa; M Norliza; S Ima Nirwana
Journal:  Adv Pharmacol Sci       Date:  2012-03-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.